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The long path to pregnancy: early experience
with dual anonymous gamete donation in a
European in vitro fertilisation referral centre
Eric Scott Sills1,3*, Lyubov O Mykhaylyshyn2, Ulyana S Dorofeyeva2, David J Walsh1, Umme Salma1,
Ahmed B Omar1, Graham D Coull1, Ileana A David1, Kathy M Brickell1, Olga M Tsar1,2, Anthony PH Walsh1
Abstract
Background: This investigation describes features of patients undergoing in vitro fertilisation (IVF) and embryo
transfer (ET) where both gametes were obtained from anonymous donors.
Methods: Gamete unsuitability or loss was confirmed in both members of seven otherwise healthy couples
presenting for reproductive endocrinology consultation over a 12-month interval in Ireland. IVF was undertaken
with fresh oocytes provided by anonymous donors in Ukraine; frozen sperm (anonymous donor) was obtained
from a licensed tissue establishment. For recipients, saline-enhanced sonography was used to assess intrauterine
contour with endometrial preparation via transdermal estrogen.
Results: Among commissioning couples, mean±SD female and male age was 41.9 ± 3.7 and 44.6 ± 3.5 yrs,
respectively. During this period, female age for non dual anonymous gamete donation IVF patients was 37.9 ± 3
yrs (p < 0.001). Infertility duration was ≥3 yrs for couples enrolling in dual gamete donation, and each had ≥2 prior
failed fertility treatments using native oocytes. All seven recipient couples proceeded to embryo transfer, although
one patient had two transfers. Clinical pregnancy was achieved for 5/7 (71.4%) patients. Non-transferred
cryopreserved embryos were available for all seven couples.
Conclusions: Mean age of females undergoing dual anonymous donor gamete donation with IVF is significantly
higher than the background IVF patient population. Even when neither partner is able to contribute any gametes
for IVF, the clinical pregnancy rate per transfer can be satisfactory if both anonymous egg and sperm donation are
used concurrently. Our report emphasises the role of pre-treatment counselling in dual anonymous gamete
donation, and presents a coordinated screening and treatment approach in IVF where this option may be
contemplated.
Background
For some patients, parenthood hinges on the successful
completion of a medical odyssey comprising a fretful
maze of tests and procedures. Among the advanced
reproduction techniques currently available, one of the
more complicated is anonymous donor oocyte IVF. The
complexity and cost of this treatment relates to the
interlock of screening and clinical management of the
oocyte donor, the embryo recipient, and the sperm
source (usually, the recipient’s partner). Although anon-
ymous donor oocyte IVF generally requires eggs to be
collected fresh, since cryopreserved spermatozoa have
long been available from tissue establishments ("sperm
banks”) this has made anonymous acquisition of male
gametes comparatively simple. But while the frequency
of IVF incorporating either donor oocyte [1] or donor
sperm has trended upward recently, dual anonymous
gamete donation has rarely (if ever) been previously
reported. With a view to characterise this type of ferti-
lity treatment better, our investigation sought to provide
a clinical summary of IVF couples who undergo dual
anonymous gamete donation.
* Correspondence: drscottsills@sims.ie
1Division of Reproductive Endocrinology, The Sims Institute/Department of
Obstetrics & Gynaecology, School of Medicine, Royal College of Surgeons in
Ireland; Dublin, Ireland
Full list of author information is available at the end of the article
Sills et al. Reproductive Health 2010, 7:20
http://www.reproductive-health-journal.com/content/7/1/20
© 2010 Sills et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Methods
Medical records were reviewed for all in vitro fertilisa-
tion (IVF) cases at Sims International Fertility Clinic
(Sims IVF/Dublin, Ireland) to identify cases where both
oocyte and sperm from anonymous gamete donors was
used during treatment. We studied de-identified IVF
records of all couples who completed embryo transfer
during 2009. Given the emerging regulatory environ-
ment for assisted fertility services in Ireland, cycle com-
mencement and monitoring occurred in Dublin, while
embryo transfer was performed at our affiliate clinic site
in Ukraine (Intersono, Lviv).
IVF patients were considered for dual anonymous
gamete donation if prior donor oocyte IVF treatment
using partner sperm had failed. However, in cases where
prior ovarian response to gonadotropin ovulation induc-
tion was poor and where the male partner evaluation
also identified severe abnormality with semen para-
meters and/or sperm DNA fragmentation (and no
donor gametes were used), couples could request to
move directly to dual anonymous gamete donation with-
out first having to complete one cycle of anonymous
donor sperm or egg IVF. Anonymous oocyte donors
underwent comprehensive medical and psychological
evaluation in Ukraine, as described previously [2]. Reci-
pients had their initial reproductive endocrinology con-
sultation and all pre-embryo transfer monitoring in
Ireland. Anonymous oocyte donor counselling was pro-
vided by an accredited psychologist before beginning
gonadotropins in Lviv; recipients and their partners
completed parallel counselling in Dublin. All recipient
couples participating in dual anonymous gamete dona-
tion had already matriculated into Ireland’s national
adoption counselling protocol. These patients were in
various stages of assessment as adopters, involving a
comprehensive extramural evaluation designed to pre-
pare them for parenthood via adoption. The process to
adopt a child had therefore triggered a recommendation
letter from consultants in support of the couple’s adop-
tion application, and redacted summaries of those coun-
selling narratives were evaluated for this study.
After undergoing further counselling specifically on
dual anonymous gamete donation, couples were offered
this treatment as an alternative to adoption. They were
apprised of the procedure’s complexity and the interna-
tional nature of the treatment was acknowledged. Each
recipient selected an anonymous oocyte donor via
secure internet portal with an electronic lock-out
mechanism to prohibit multiple recipients from acces-
sing the aggregate donor pool at the same time. Follow-
ing registration of each provisional donor-recipient
match, the corresponding anonymous oocyte donor
entry was deleted from the donor library [2], thus
creating a 1:1 ratio for each recipient and their anon-
ymous oocyte donor. Anonymous sperm samples were
individually ordered from a pre-screened cryobank
inventory provided by a licensed tissue establishment.
No two recipients requested anonymous sperm from the
same anonymous donor.
After match verification and institutional receipt of
anonymous (frozen) donor sperm, the anonymous
oocyte donor commenced controlled ovarian hypersti-
mulation. Programmed transvaginal ultrasound-guided
oocyte collection followed 36 h after s.c. hCG adminis-
tration. Anonymous donor sperm was used to fertilise
all freshly retrieved eggs obtained from the anonymous
oocyte donor; intracytoplasmic sperm injection (ICSI)
was performed in all cases due to high variation in post-
thaw sperm motility. The recipient underwent endome-
trial preparation by transdermal estrogen. Fresh embryo
transfer occurred at the blastocyst stage under abdom-
inal ultrasound guidance, and any non-transferred
embryos were cryopreserved [3]. Supplementary luteal
phase support was provided for all recipients, who
returned for hCG testing 12-14 d after embryo transfer.
Progesterone was discontinued for non-pregnant
patients. After oocyte retrieval, donor health and overall
satisfaction with the anonymous donation process was
elicited by nursing and medical staff. Clinical pregnan-
cies among recipients were recorded for analysis.
For all dual donation couples, recipient and partner
age were tabulated as was age of the anonymous oocyte
donor (the ages of anonymous sperm donors were not
ascertained). The following laboratory parameters were
also evaluated: number of oocytes collected from anon-
ymous donor, number of 2pn embryos generated after
fertilisation, number of embryos transferred, and num-
ber of non-transferred cryopreserved embryos. Addition-
ally, infertility duration and history of prior fertility
treatments were recorded for all recipients.
Results
A total of 1,003 non-donor embryo transfer cycles were
completed at the monitoring site during the 12-month
study interval. During this period, mean±SD age of all
patients initiating IVF treatment at the monitoring site
was 37.9 ± 3 yrs. Couples embarking on IVF with dual
anonymous gamete donation (n = 7), had mean±SD
female age of 41.9 ± 3.7 yrs. Male age was 44.6 ± 3.5 yrs
in this group (dual anonymous gamete donation female
recipient age vs. general IVF female patient age, p <
0.001 by Student’s t-test).
For all females who enrolled in dual anonymous
gamete donation, infertility duration was at least 3 yrs.
All these couples had at least two prior failed fertility
treatments using native oocytes, and five of seven
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couples had already completed one unsuccessful cycle of
anonymous donor oocyte IVF (using partner sperm).
The other two couples (who had not done anonymous
donor oocyte IVF previously) had experienced total fer-
tilisation failure of native oocytes when partner sperm
was used for IVF+ICSI. In these two cases, both oocyte
quantity and quality were profoundly impaired and the
partner’s sperm DNA fragmentation exceeded 40%.
Although the problem of bilateral gamete impairment
could have been remedied in a stepwise fashion by the
incremental introduction of either anonymous donor
sperm or oocytes for IVF, this therapeutic option was
rejected by these two couples.
All recipient couples were familiar with traditional
adoption in Ireland; there was no uniform reason why
couples decided not to pursue adoption. Uncertainty
about (or disagreement with) intercountry adoption pol-
icy in Ireland was expressed by 6 of 7 couples who
embarked on IVF with dual gamete donation. Additional
counselling focusing on dual anonymous gamete dona-
tion found the seven couples to be good candidates for
this treatment, and since adoption in Ireland is typically
an international transaction anyway, the Ukrainian com-
ponent was not considered objectionable. Figure 1 sum-
marises options considered by fertility patients in this
sample.
For anonymous oocyte donors, mean±SD age was
27.1 ± 3 yrs, and all were Caucasian non-smokers with
at least one child from an unassisted pregnancy. Recipi-
ents in Ireland were matched to their first-choice anon-
ymous oocyte donor in Ukraine in each case, although
one patient completed two dual-donor IVF cycles using
a different anonymous oocyte donor for her second
attempt. Within six weeks of anonymous donor acces-
sion, screening was completed for all anonymous oocyte
donors in accordance with the European Union Tissues
& Cells Directive [2004/23/EC]; a karyotype was
obtained on each donor in addition to statutory require-
ments [2]. No aneuploidy was identified in any donor
from this series. Anonymous donor sperm was commer-
cially obtained in standard cryovials from a licensed tis-
sue establishment, and arrived at the Ukrainian clinical
site within four weeks of order placement.
From anonymous oocyte donors, an average of 21
oocytes was obtained (range = 10-24). After fertilisation
with anonymous donor sperm, 17.6 ± 4.5 advanced to
the 2pn stage. Mean number ±SD of embryos trans-
ferred in this series was 2.1 ± 0.3, and commissioning
couples had an average of 7.6 non-transferred embryos
cryopreserved for storage (range = 1-17). Embryo trans-
fer was completed in all seven cases, but one couple
underwent two transfers. Clinical pregnancy was
achieved for five (5/7 = 71.4%) patients. Transvaginal
ultrasound at 7-10 weeks’ gestation confirmed an intrau-
terine pregnancy for five patients, and two of these had
twins (40% multiple gestation rate/transfer, see Table 1).
Figure 1 The IVF experience: pathways after failure. Schematic of options for study patients failing to achieve pregnancy after in vitro
fertilisation (IVF), including those with prior experience with anonymous donor oocyte (DER) treatments. Non-medical pathways are shown in
red. Gray bands indicate mandatory psychological counselling interventions at various treatment stages (Ψ1 and Ψ2).
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Discussion
Donor gamete IVF typically joins the path to pregnancy
as a late entry. As a fertility treatment generally reserved
for the most refractory cases, anonymous donor oocyte
IVF is usually preceded by multiple failed treatment
cycles. For such patients, substantial emotional stress
may coalesce around donor gamete IVF because of feel-
ings of reproductive inadequacy or disappointment.
Indeed, some fertility patients never accept the donor
gamete alternative and steadfastly resist any reproduc-
tive option involving gamete donation [4]. These psy-
chological factors should not be underestimated; they
often figure prominently in the decision to disengage
from fertility treatments [5,6]. Remarkably, the stress
release achieved by stopping all fertility treatment can
be followed by an unassisted conception, even at
advanced age [7].
While previous investigations have focused on either
anonymous donor oocyte or sperm with IVF, this work
is the first to collect data on an IVF patient series where
both gametes derived from anonymous donors. Irrespec-
tive of the clinical indication(s) leading to use of donor
gametes with IVF, this treatment modality brings unique
and sensitive issues not encountered with other assisted
fertility pathways. For example, a successful anonymous
donor oocyte IVF cycle may introduce family concerns
regarding a “separated biological and social parenthood”
[8], and feelings of fathers who use anonymous donor
sperm to establish their family have been similarly
depicted [9]. Considerable research has also focused on
how anonymous oocyte [10] and sperm [11] donors
regard the total donation experience. The anonymous
donor has been variously portrayed as the shadowy and
ambiguous figure of ‘another man’, the intelligent medi-
cal student, or the donor as ‘family man’, with children
of his own who wants to help infertile men father chil-
dren [9]. These diverse sentiments underscore the
essential requirement of psychological counselling for all
parties before commencing any fertility treatment incor-
porating donated gametes [12]. Given the psychological
issues that can accompany IVF when a single gamete
donor is used, it is plausible that such factors are com-
pounded when both gametes used in IVF are anon-
ymously donated.
It should be noted that IVF with dual anonymous
gamete donation shares some features with embryo
donation, in that neither provides a genetic linkage
between parents and offspring. Key differences must be
acknowledged between the two approaches, however.
For example, in IVF with dual anonymous gamete
donation, the commissioning couple initiates the entire
treatment sequence de novo. In contrast, donor embryo
IVF is conditional on the availability of surplus
embryos derived from someone else’s prior IVF treat-
ment. Studies on family dynamics after donor embryo
IVF have suggested higher emotional overinvolvement
and defensive responding are more often observed
along with greater secrecy about the child’s origins
[13]. Moreover, a gestational connection between
mother and child exists when either oocyte donation
or embryo donation IVF succeeds, allowing a mother
to feel that the child is “hers” and that she is a “nor-
mal” mother who conceived “naturally” [14]. Notably,
anonymous oocyte donation and embryo donation
enable patients in both IVF groups to obscure their
lack of genetic relationship to offspring, friends, or
family [15]. Some of these characteristics might be
generalisable to families where IVF with dual gamete
donation was used successfully, although this issue
awaits further study.
Table 1 Summary of clinical and laboratory characteristics observed among couples undergoing IVF with dual
anonymous gamete donation
Commissioning couple Oocyte donor age (yrs) Oocytes retrieved (n) #ET #embryos frozen outcome1
Female age (yrs) Male age (yrs)
42 50 32 13 2 0 0
27 25 2 17 0
45* 45 28 18 2 9 2
44* 45 28 21 3 4 1
43 43 28 24 2 10 0
39 39 23 21 2 12 1
45 43 24 22 2 6 1
35 47 24 22 2 6 2
41.9 ± 3.7 44.6 ± 3.5 26.4 ± 2.9 21 ± 3.6 2.1 ± 0.3 7.6 ± 5.1
Notes: Data reported as mean ± SD. ET = embryo transfer. The first case was matched to two different anonymous oocyte donors, but has yet to attain
pregnancy (17 cryopreserved embryos remain in storage for this couple)
(*) no history of anonymous donor gamete therapy before enrolling into dual anonymous donor gamete IVF treatment
1 Classification system for reproductive outcome: 0 = no pregnancy; 1 = singleton intrauterine pregnancy; 2 = twin pregnancy. Overall clinical pregnancy rate/
ET = 62.5%
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Perhaps not surprisingly, our research on IVF with dual
anonymous gamete donation revealed that each couple
undergoing this treatment develops their own narrative
describing how this key decision is made. A theme of
“engagement with technology” as a means to attain par-
enthood was commonly identified in recipient counsel-
ling sessions here. While the notion of dual gamete
donation IVF was never portrayed as an ideal route to
pregnancy, the alternative of childlessness was clearly
regarded as unacceptable. Moreover, all seven recipient
couples were conversant with traditional adoption and
none objected to having a family in this way (some actu-
ally preferred traditional adoption over medical interven-
tions like IVF). But in Ireland, a government-regulated
state adoption scheme does not favour continuation of
fertility treatments in parallel to the adoption process.
Curiously, while this agency “encourages” prospective
adopters “to complete fertility investigations prior to pur-
suing adoption” [16], in practice all patients in our study
group had been told to stop fertility treatments while on
the adoption wait-list, or risk being disqualified for adop-
tion. As Irish legislation to address assisted reproductive
treatments is contemplated, policies of making traditional
adoption contingent on an applicant’s discontinuation of
all clinical assistance to achieve a pregnancy should be
re-examined.
A novel feature of this dual anonymous donor gamete
IVF programme is that neither gamete donor was of
Irish origin. As previously reported, the paucity of
domestic anonymous gamete donors in Ireland together
with the regulatory vacuum with respect to all assisted
fertility treatments frustrates the provision of this service
here [2]. For these couples, the role of the clinical site in
Ireland was limited to cycle monitoring while (anon-
ymous donor) oocyte retrieval and embryo transfer were
performed in Ukraine. This circumstance may change
when Ireland implements comprehensive legislation gov-
erning assisted reproduction that addresses anonymous
gamete donation. Considerable public debate has already
transpired in other jurisdictions about the wishes of
donor-conceived people, as this group has gained a
voice regarding their experience of not being able to
access basic information about their genealogical heri-
tage [17]. The rights and needs of donor-conceived peo-
ple regarding their access to identifying information
about their genetic parents [18] have special relevance
when neither “social” parent has a genetic connection to
their children, as in IVF with dual anonymous gamete
donation. The treatment we describe here brings for-
ward themes similar to those identified with donor
oocyte IVF, regarding parenthood as well as the cogni-
tive and socioemotional development of the resulting
offspring [19]. Longitudinal studies of children resulting
from anonymous donor gamete IVF have particularly
focused on disclosure (openness) vs. non-disclosure
(secrecy) [20]. Earlier research has suggested that many
infertile couples who have benefited from assisted ferti-
lity treatments using donated gametes have no intention
to disclose this fact to their offspring [21,22]. Indeed,
our patients variably expressed a “protective worry” that
if disclosure were to be made compulsory, the reaction
or attitude of the donor/s at some point in the future
would be unpredictable, and might not be positive for a
previously unknown child conceived from their gametes.
Interestingly, this tendency to maintain confidentiality
has been noted even among fertility patients in coun-
tries where legislation mandates disclosure of donor
identity when the offspring reach adulthood [23]. These
investigations underscore the role of careful pre-treat-
ment counselling which, among other things, helps
anticipate parenting strategies for would-be parents after
particular fertility interventions.
Conclusions
Should anonymous gamete donation be restricted by
statute in Ireland, then Irish patients who specifically
seek this treatment may travel elsewhere for this repro-
ductive option. Evidence exists supporting such a conse-
quence in the E.U., as in Sweden sperm donors are
required by law to be identifiable, while anonymous
sperm donation is permitted in Denmark. The shortage
of Swedish sperm donors has contributed to cross-bor-
der “reproductive tourism” between Sweden and Den-
mark [24]. How regulation of clinical treatments
incorporating anonymous donor gametes in Ireland will
develop is uncertain, but the current research offers
early insights regarding patients most directly impacted
by such legislation.
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